News | August 06, 2021
Strides to acquire US manufacturing facility of Endo for $24 mn
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
It had an estimated market size of US $ 32 million as of June 2021
Deal for 100 million doses with additional 100 million through 2023
Arrow is the marketing partner in US
It is part of the company’s pain/analgesics portfolio of OTC products
Aditya Puri former MD of HDFC bank joins Solara board as chairman
Robust demand for the product across the Middle East, Africa and Latin America
FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone every minute with optional real-time glucose alarms
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
Complementary business models are the reason for the acquisition
Subscribe To Our Newsletter & Stay Updated
